Magnetic seizures: a new hope for psychosis?

NCT ID NCT06581302

Recruiting now Disease control Sponsor: Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new treatment called magnetic seizure therapy (MST) for people with psychotic disorders like schizophrenia. MST uses magnetic pulses to trigger a controlled seizure in the brain, aiming to improve symptoms when added to standard antipsychotic medications. The trial will enroll 50 adults aged 18-55 and measure changes in symptoms, thinking, and brain activity over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic seizure therapy (MST) using a MagPro MST device, plus antipsychotic medications (e.g., olanzapine, risperidone)
What this could lead to: If it works, this could offer a safer, more targeted brain stimulation option for people with psychosis who don't fully respond to medication alone.
What could go wrong: This is an early, small study (50 people) with no control group, so results may not be conclusive. MST is still experimental, and its long-term benefits or risks are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOTIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychotic disorder Psychotic Disorders schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSYCHOTIC DISORDERS

Contacts and locations

Locations

Shanghai Mental Health Center
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200030, China
Shanghai Mental Health Center
RECRUITING

Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.